Finland· FI-REL-REL53344
Rhokiinsa
A netarsudil product containing netarsudil mesylate, registered in Finland by Santen Oy. The same ATC class is registered in 10 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Netarsudil is registered in 10 of 19 countries.
Countries holding a registration under ATC S01EX05 (netarsudil), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 6 of them publish a price we can compare per daily dose
Netarsudil · ATC S01EX05
10 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Polandprice
- United Statesprice
The record
At a glance
Fimea (Finland)- Active substance
- Netarsudil mesylate
- Manufacturer
- Santen Oy
- Country
- Finland (FI)
- ATC code
- S01EX05
- ATC class
- Netarsudil
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Netarsudil in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumRhokiinsa 200 µg/mlSanten
- CzechiaRHOKIINSASanten OY, Tampere
- IrelandRhokiinsa 200 micrograms/ml eye drops, solutionSanten OY
- PolandRhokiinsaSanten Oy
- SwedenRhokiinsa 200 mikrogram/ml Ögondroppar, lösningSanten Oy
- United StatesRhopressaAlcon Laboratories, Inc.
- IcelandRhokiinsaSanten Oy*
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Rhokiinsa
- Liechtenstein · Rhokiinsa
- Norway · Rhokiinsa
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/7308dfe1-1892-4e27-a349-be40bd4e2d09 GET /v1/drugs/7308dfe1-1892-4e27-a349-be40bd4e2d09?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": null,
"form": "silmätipat, liuos",
"route": "Silmän pinnalle",
"ddd_unit": null,
"strength": "200 mikrog/ml",
"atc_label": "netarsudiili",
"ma_number": null,
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": "EU/1/19/1400/001",
"fimea_rel_id": "REL53344",
"authorised_at": "2019-11-19"
}See everything about netarsudil.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.